eConsent is available via REDCap, giving study teams a new tool to use as part of the informed consent process for minimal risk studies. This functionality provides the ability to consent remote participants or participants in clinic via tablets or touchscreen device. Participants will have the capability to sign electronically with a stylus, mouse, or finger. Once the consent form is submitted, participants will receive an email that includes a PDF attachment with a copy of the signed consent form.
Information about the process can be found on the DOCR website. While this is a great new tool, it may not be appropriate for all study populations. If you would like receive consultations about best practices and tools for your study’s recruitment, please reach out to the Recruitment Innovation Center, supported by the Duke Clinical & Translational Science Institute.